ReviewMikrochimica acta2025
Current advances in multi-strategy collaborative sensitization for self-powered electrochemical biosensors and their applications in disease biomarker detection.
Review in Mikrochimica acta, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Self-powered electrochemical biosensors have emerged as a cutting-edge direction in disease biomarker detection due to their miniaturization potential and external power-free characteristics. Enzymatic biofuel cell-based self-powered biosensors (EBFC-SPB), a green energy conversion device that utilizes biological enzymes as catalysts to directly convert bioenergy into electricity, have become a new research hotspot owing to its operational simplicity, biocompatibility, and efficient performance in both plants and animals. However, challenges such as suboptimal catalytic efficiency, limited open-circuit voltage, and low power output have hindered its applications in human health monitoring. In recent years, researchers have developed various sensitization-enhancement strategies (including nanomaterial sensitization, nucleic acid signal amplification, enzyme catalytic enhancement, energy storage/conversion optimization, and synergistic multi-strategy approaches) to improve EBFC-SPB's detection capabilities and expand its practical applications in biofluids (such as blood, sweat, saliva, tears, interstitial fluid, and urine), thereby making significant contributions to real-time tracking and accurate detection of disease biomarkers. This review summarizes the working principles of EBFCs, analyzes the design rationale of multi-strategy synergistic sensitization in EBFC-SPB, examines its applications in human disease biomarker detection, and prospects its future research directions and potential applications.
Indexed as
Identifiers
40956468What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.